Richard J. White
Chief Tech/Sci/R&D Officer at Vicuron Pharmaceuticals LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Neil E. Reiner | M | - |
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | - |
| Sandra Leung | F | 63 | 32 years | |
| Roger Léger | M | - |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | - |
| Timothy J. Henkel | M | 65 |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | - |
| Patrick Scannon | M | 76 |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | - |
| Costantino Ambrosio | M | 81 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | - |
| Charles J. Davidson | M | - |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | - |
| Jennifer D. Copeland | F | - |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 20 years |
| Allan Collings | M | - |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | 13 years |
| Irwin Kuntz | M | - |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter R. Dolan | M | 68 | 18 years | |
| Anthony Hooper | M | 69 | 15 years | |
| Charles Sigal | M | 72 | 16 years | |
| Timothy Meeker | M | 77 | 13 years | |
| Lawrence Hamilton | M | 66 | 8 years | |
| Laurie Glimcher | M | 72 | 20 years | |
| Mark W. Durand | M | 64 | 17 years | |
| Harrison Bains | M | 80 | 16 years | |
| Dinesh Patel | M | 67 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 16 years |
| Eric M. Gordon | M | 78 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 1 years |
| Priya Jambhekar | F | - | 3 years | |
| Dov Goldstein | M | 56 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 15 years |
| Steven B. Ratoff | M | 81 | 16 years | |
| Peter Nicklin | M | 61 | 14 years | |
| Beth Anne Piper | M | - | 4 years | |
| Robert Peach | M | 68 | 9 years | |
| Charles M. Urbain | M | 70 | 14 years | |
| Matthew Ros | M | 57 | 17 years | |
| Zola P. Horovitz | M | 89 | - | |
| Lie Ping Chen | M | - | - | |
| Robert Roche | M | 57 | 6 years | |
| Bruce I. Lavine | M | 57 | 3 years | |
| Michael Tardugno | M | 73 | 2 years | |
| Joachim von Roy | M | 79 | - | |
| James New | M | 70 | 12 years | |
| George Zavoico | M | - | - | |
| Kenneth Anderson | M | - | 17 years | |
| Steven Gelone | M | 56 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 1 years |
| Donald Handley | M | - | 3 years | |
| Raymond T. Keane | M | 65 | 20 years | |
| Murdo Gordon | M | - | 29 years | |
| David Wishart | M | - | 10 years | |
| Benjamin Winograd | M | 63 | 9 years | |
| Karen LaRochelle | F | 57 | 20 years | |
| Kirsten Detrick | F | 59 | 13 years | |
| Emmanuel Blin | M | 54 | - | |
| Stephen McAndrew | M | - | 8 years | |
| Elliott Levy | M | 65 | 17 years | |
| Ning Yan | M | - | 7 years | |
| Richard Colonno | M | 74 | 16 years | |
| Robert W. Morrissey | M | 66 | 6 years | |
| Douglas C. Plessinger | M | 55 | 6 years | |
| Larry Mallis | M | - | - | |
| John Golubieski | M | 59 | 16 years | |
| Paul Herbert Chew | M | 72 | 9 years | |
| Cheryl Capps | F | 62 | 13 years | |
| Lucius Allen | M | - | - | |
| Patricia Bellinger | F | 63 | 5 years | |
| Jane A. Kramer | F | 68 | 11 years | |
| Rick Winningham | M | 64 | 4 years | |
| Patrick Colin | M | - | - | |
| James G. Ham | M | 74 | 7 years | |
| Michael A. Popson | M | - | 6 years | |
| Timothy McNamara | M | 67 | 9 years | |
| William Jones | M | 60 | 12 years | |
| Bruce Wendel | M | 70 | 14 years | |
| Barry A. Labinger | M | 60 | 3 years | |
| James R. Ellinghausen | M | 65 | 8 years | |
| Robert Francis Doman | M | 74 | 8 years | |
| Tim Tyson | M | 71 | 8 years | |
| Susan Mahony | M | 59 | 5 years | |
| Steven R. Arikian | M | 65 | 2 years | |
| John L. McGoldrick | M | 83 | 10 years | |
| Steven E. Benner | M | 64 | 7 years | |
| Timothy P. Cost | M | 65 | 5 years | |
| Gregg L. Bienstock | M | 59 | 1 years | |
| Gregory A. Fischer | M | - | 12 years | |
| David Milligan | M | 83 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 8 years |
| Anthony A. McBride | M | 60 | - | |
| Helen Torley | M | 61 | 5 years | |
| Gary Dickinson | M | 72 | 4 years | |
| Louis T. DiFazio | M | 86 | 7 years | |
| Jeffrey Hatfield | M | 66 | 19 years | |
| Marino Carol | F | - | 8 years | |
| Stephen K. Carter | M | 85 | 13 years | |
| N. Coles | M | 63 | - | |
| Robert L. Simon | M | 79 | 13 years | |
| Walter R. Maupay | M | 84 | - | |
| Alan Dunton | M | 70 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 1 years |
| Nicole Onetto | M | 71 | 6 years | |
| Christine Poon | F | 71 | 3 years | |
| Frederick B. Oleson | M | - | 9 years | |
| Barry Wilson | M | 80 | 13 years | |
| William R. Miller | M | 95 | 27 years | |
| John D. Macomber | M | 96 | 5 years | |
| Kenneth E. Weg | M | 85 | 10 years | |
| Stephen Sadove | M | 72 | 10 years | |
| Julius A. Vida | M | 95 | 18 years | |
| Luigi Lenaz | M | 83 | 19 years | |
| Robert Jones | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 95.00% |
| Canada | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard J. White
- Personal Network
